GL
Gert Jacobus Laubscher

Publications (10)

Accelerating Discovery: A Novel Flow Cytometric Method for Detecting Fibrin(ogen) Amyloid Microclots Using Long COVID as a Model
Article scientifique · 2023
Treatment of Long COVID symptoms with triple anticoagulant therapy
Article scientifique · 2023
Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system
Article scientifique · 2022
Relative hypercoagulopathy of the SARS-CoV-2 Beta and Delta variants when compared to the less severe Omicron variants is related to TEG parameters, the extent of fibrin amyloid microclots, and the severity of clinical illness.
Article scientifique · 2022
Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC)
Article scientifique · 2022
Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/ Post-Acute Sequelae of COVID-19 (PASC)
Article scientifique · 2022
Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
Article scientifique · 2021
Early management of severe COVID-19 coagulopathy should be guided by TEG ® , microclot and platelet mapping
Article scientifique · 2021
Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report
Article scientifique · 2020
Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma
Article scientifique · 2020

Domaines principaux

Sciences de la santé10

Statistiques

Consultations27
Téléchargements0